Drug intelligence / Profile preview

AURKB siRNA

Development stage
Unknown
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous, Intratumoral, Subcutaneous
01

Overview

AURKB siRNA is a small interfering RNA (siRNA) designed to target and silence the expression of Aurora kinase B (AURKB), a key mitotic serine/threonine kinase involved in chromosome segregation, cytokinesis, and cell cycle progression. AURKB is frequently overexpressed in various cancers, including esophageal cancer, gastric cancer, and glioblastoma, where it contributes to tumor progression, chromosomal instability, and drug resistance. It is also implicated in pathological retinal angiogenesis and pulmonary arterial hypertension. By sequence-specifically binding to and promoting the degradation of AURKB mRNA, AURKB siRNA inhibits cell proliferation, induces cell cycle arrest, and promotes apoptosis. While primarily utilized as a research tool to investigate the biological functions of AURKB and validate it as a therapeutic target, preclinical studies have also explored its therapeutic potential using various delivery systems such as lipid nanoparticles and extracellular vesicles.

Other names
Aurora kinase B siRNAAurora kinase B small interfering RNAAURKB small interfering RNAsiRNA targeting AURKBsiRNA targeting Aurora kinase B

Beyond the preview

Go deeper on AURKB siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AURKB siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call